Evidence map›Paper›PMID 24298202›Full record

ArticleDegenerative neurological and neuromuscular disease2012

Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Nader Pouratian, Sandeep Thakkar, Won Kim, Jeff M Bronstein

Abstract read
In one paragraph

Article in Degenerative neurological and neuromuscular disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.Movement disorders : official journal of the Movement Disorder Society · 2016
    Trial
  2. Review
  3. Review
  4. The Effects ofNutrients · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. [High frequency stimulations change the phase-locking relationship between neuronal firing and the rhythms of field potentials].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2018
    Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nader PouratianDepartments of Neurosurgery, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles ; Bioengineering, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles.
Sandeep Thakkar
Won Kim
Jeff M Bronstein

Funding

UCLA Neurosurgery Research Training and Education ProgramR25NS079198 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIAU, LINDA M · 2012 to 2021
$1.2M
Electrophysiologic and Anatomic Basis of BOLD fMRIK23EB014326 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POURATIAN, NADER · 2012 to 2016
$946k
NIBIB NIH HHS K23 EB014326NINDS NIH HHS R25 NS079198
6 · The paper itself

Abstract

Deep brain stimulation (DBS) surgery has become increasingly utilized in the treatment of advanced Parkinson's disease. Over the past decade, a number of studies have demonstrated that DBS is superior to best medical management in appropriately selected patients. The primary targets for DBS in Parkinson's disease include the subthalamic nucleus and the internal segment of the globus pallidus, both of which improve the cardinal motor features in Parkinson's disease. Recent randomized studies have revealed that both targets are similarly effective in treating the motor symptoms of Parkinson's disease, but emerging evidence suggests that the globus pallidus may be the preferred target in many patients, based on differences in nonmotor outcomes. Here, we review appropriate patient selection, and the efficacy and safety of DBS therapy in Parkinson's disease. Best outcomes are achieved if the problems of the individual patient are considered when evaluating surgical candidates and considering whether the subthalamic nucleus or the globus pallidus internus should be targeted.

Indexed as

deep brain stimulationdyskinesiaglobus pallidusParkinson’s diseasesubthalamic nucleus

Identifiers

PMID24298202
PMCPMC3843969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.